论文部分内容阅读
宮頸癌放射治疗已有很大进展,总存活率比1955年以前提高10％左右。Decker氏(1961)报导在美国Mayo Clinic 5年存活率为49％,10年存活率为40％。在英国Manchester各为39.4％及29.6％。夏氏(1961)报告列宁格勒肿瘤研究所5年存活率为65.2％。存活率的提高主要由于晚期疗效的提高。 Kottmeier氏(1959)总結了78个单位的98218例,也分析了Radiumhemmet的2756例,其5年总存活率为51.1％。治疗原則仍与在1954年第七屆国际放射学会提出者同,即治疗以腔内鐳疗加上外照射而补充宮旁组織剂量的方式为主。惟镭源强
Cervical cancer radiotherapy has made great progress and the overall survival rate has increased by about 10% compared with that before 1955. Decker’s (1961) reported that the Mayo Clinic in the United States had a five-year survival rate of 49% and a 10-year survival rate of 40%. In Manchester, England was 39.4% and 29.6% respectively. Xia (1961) reported that the 5-year survival rate of Leningrad Cancer Institute was 65.2%. The increase in survival rate is mainly due to the increase in late-stage efficacy. Kottmeier’s (1959) summarized 98,218 of 78 units and also analyzed 2,556 Radiumhemmets, with a 5-year overall survival rate of 51.1%. The principle of treatment is still the same as that proposed by the 7th International Society of Radiology in 1954, that is, the treatment of intrauterine radium therapy plus external irradiation to supplement the dose of para-area tissue. Only radium source strong